Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ADAGIO THERAPEUTICS, INC.

(ADGI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Rising Monday Afternoon

11/29/2021 | 02:04pm EST


ę MT Newswires 2021
All news about ADAGIO THERAPEUTICS, INC.
01/13Wall Street Set for Narrow Gains; US Wholesale Prices Rise Less Than Expected in Decemb..
MT
01/13Health Care Stocks Mixed Pre-Bell Thursday
MT
01/13ADAGIO THERAPEUTICS : Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants a..
PU
01/13ADAGIO THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financial Statements a..
AQ
01/13Adagio Therapeutics Reports Neutralization Activity Against Omicron in Phase 2/3 Clinic..
MT
01/12Adagio Therapeutics Details Omicron-Related Efforts
DJ
01/12Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants ..
GL
01/12Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants ..
GL
01/12Adagio Therapeutics, Inc. Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Var..
CI
01/07NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
DJ
More news
Analyst Recommendations on ADAGIO THERAPEUTICS, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -238 M - -
Net cash 2021 436 M - -
P/E ratio 2021 -2,97x
Yield 2021 -
Capitalization 733 M 733 M -
EV / Sales 2021 -
EV / Sales 2022 8,52x
Nbr of Employees -
Free-Float -
Chart ADAGIO THERAPEUTICS, INC.
Duration : Period :
Adagio Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADAGIO THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 4
Last Close Price 6,59 $
Average target price 8,33 $
Spread / Average Target 26,5%
EPS Revisions
Managers and Directors
Tillman U. Gerngross President, Chief Executive Officer & Director
Jane Pritchett V. Henderson Chief Financial Officer
RenÚ Russo Chairman
Laura Walker Chief Scientific Officer
Lynn Connolly Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
ADAGIO THERAPEUTICS, INC.-9.23%733
GILEAD SCIENCES, INC.-7.26%84 470
REGENERON PHARMACEUTICALS-4.16%63 282
VERTEX PHARMACEUTICALS3.18%57 608
WUXI APPTEC CO., LTD.-12.95%47 873
BIONTECH SE-37.66%38 812